Lipid Nanomachines Overcome Endo−Lysosomal Barrier
The presence of endo−lysosomal barrier limits the intracellular delivery of therapeutic biologics, but our lipid nanomachines bypass this barrier and improve the delivery efficiency regardless of the types of cargo and target cell.